The bill delays PAMA price cuts until Jan. 1, 2027 and updates the data collection period to be used to establish 2027 lab rates from 2019 to 2025.

NEW YORK – T2 Biosystems said on Tuesday that it will immediately wind down its operations and liquidate the company.

The agency said that impurities in the company's Safe-T-Fill EDTA tubes may be related to false positive lead testing results reported by users of Magellan Diagnostics' lead detection tests.

The coalition will invest the money in six collaborative research projects focused on pancreatic, ovarian, and esophageal cancers, as well as cancer predisposition syndromes.

The 15-minute test runs on the Diasorin Liaison Nes system and obviates the need for molecular confirmation of negative rapid immunoassay results.

The newly formed coalition aims to increase access to noninvasive diagnostics for metabolic dysfunction-associated steatotic liver disease (MASLD).

The test integrates the measurements of five proteins to assess if patients have the brain pathology characteristic of Alzheimer's disease.